Cite
HARVARD Citation
Cherney, D. et al. (2021). Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials. Clinical cardiology. 44 (8), pp. 1139-1143. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cherney, D. et al. (2021). Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials. Clinical cardiology. 44 (8), pp. 1139-1143. [Online].